Midwest Peptide sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are sold for research use only (RUO), are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration. Full disclaimer.
For research purposes only. This compound is not FDA approved. All data presented is from clinical trials for educational reference.

Out of Stock
This product is currently out of stock. Enter your email and we'll notify you when it's available again.
Bundle & Save
Discount applies automatically at checkout once your cart subtotal hits the tier.
For In Vitro Research Use Only — Not for Human or Veterinary Use
Intended Use: This compound is intended strictly for in vitro research applications only. It is not approved for human or animal use and may not be used in food, drugs, cosmetics, or diagnostic procedures.
⚠️ Legal Disclaimer: This product and associated information have not been evaluated by the FDA. No statement should be interpreted as a claim to diagnose, treat, cure, or prevent any condition. Use is strictly limited to qualified research professionals in certified laboratories.
Terms of Sale: By purchasing from Midwest Peptide, the buyer affirms they are a qualified researcher or institution, fully responsible for proper handling, storage, and usage in compliance with all applicable laws and regulations. All sales are final.
This research peptide blend combines tesamorelin (a stabilized GHRH analog) with ipamorelin (a selective GHS-R1a / ghrelin receptor agonist). In research models, the two molecules activate parallel pathways of the growth hormone axis. Supplied strictly for Research Use Only.
Both blends pair a GHRH analog with ipamorelin, but they use different GHRH backbones. Tesamorelin is an N-terminally modified GHRH(1-44) analog. CJC-1295 is a GHRH(1-29) analog. The two have distinct half-life and receptor-binding profiles in published research.
Tesamorelin stimulates pituitary GH release via the GHRH receptor while ipamorelin stimulates the same cells via the GHS-R1a (ghrelin) receptor. The combined GHRH+GHRP mechanism produces a synergistic GH pulse in research models that neither molecule produces alone.
Other research peptides in this category
Research articles and insights related to Tesa/Ipa Blend

Explore how ipamorelin selectively targets the ghrelin receptor GHS-R1a, its role as a growth hormone secretagogue, and research on cortisol and prolactin.
April 29, 2026

Learn how to buy CJC 1295 Ipamorelin for research. Explore sourcing options, quality considerations, and compliance for preclinical studies.
April 29, 2026

Tesamorelin metabolic syndrome research integrating visceral fat, glucose regulation, lipid profile, inflammatory markers, and hepatic steatosis endpoints. For research use only.
April 24, 2026

Tesamorelin lean mass research covering body composition preservation, muscle protein synthesis, muscle quality, and sarcopenia model research. For research use only.
April 24, 2026
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
The Tesamorelin/Ipamorelin blend is studied in preclinical research on GHRH and GHRP receptor signaling, somatotroph function, growth hormone pulsatility, IGF-1 axis dynamics, and visceral adipose tissue endpoints. All cited studies are conducted in rodent or in-vitro systems.
Every batch of the Tesamorelin/Ipamorelin blend ships with a third-party COA verifying purity by HPLC (>=99%), identity by mass spectrometry, and the per-component mass ratio. The batch-specific COA is published on this product page before purchase.
Lyophilized blend is stored at -20C for long-term storage and 2-8C for short-term use within 30 days. Avoid repeated freeze-thaw cycles. Store in original sealed vials, protected from light.
Tesamorelin is FDA-approved for one specific indication. Ipamorelin is not FDA-approved. The blend supplied here is for laboratory and research use only and is not approved for diagnostic, therapeutic, or human use.

A strategic peptide combination engineered to enhance gh release through synchronized GHRH and ghrelin receptor activation in experimental research models. Premium Research Peptide.